LCP
EXAS

Legacy Capital Partners’s Exact Sciences EXAS Stock Holding History

Legacy Capital Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-17,000
Closed -$241K – 117
2014
Q1 		$241K Hold
17,000
– – 0.17% 97
2013
Q4 		$200K Hold
17,000
– – 0.14% 101
2013
Q3 		$201K Hold
17,000
– – 0.15% 96
2013
Q2 		$237K Buy
+17,000
New +$185K 0.18% 90

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Legacy Capital Partners's EXAS Position: Q2 2014 in Review

Legacy Capital Partners sold out of Exact Sciences (EXAS) in Q2 2014, closing a stake of 17,000 shares — an estimated $241K sold.

Legacy Capital Partners first reported a position in EXAS in Q2 2013 and held it in 4 quarters. The position peaked at $241K in Q1 2014. 156 funds tracked by Wall St. Rank hold EXAS as of Q2 2014.

  • Legacy Capital Partners reported no remaining Exact Sciences position as of Q2 2014 after selling out during the quarter.
  • Legacy Capital Partners sold 17,000 Exact Sciences shares in Q2 2014, an estimated $241K.
  • Legacy Capital Partners first reported a position in Exact Sciences in Q2 2013 and held it in 4 quarters.
  • Legacy Capital Partners's Exact Sciences position peaked at $241K in Q1 2014.
  • 156 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2014.

Based on Legacy Capital Partners's 13F filing for Q2 2014, filed 11 Aug 2014.